Lantern Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lantern Pharma and other ETFs, options, and stocks.About LTRN
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184.
CEOPanna L. Sharma
CEOPanna L. Sharma
Employees24
Employees24
HeadquartersDallas, Texas
HeadquartersDallas, Texas
Founded2013
Founded2013
Employees24
Employees24
LTRN Key Statistics
Market cap40.45M
Market cap40.45M
Price-Earnings ratio-2.05
Price-Earnings ratio-2.05
Dividend yield—
Dividend yield—
Average volume68.55K
Average volume68.55K
High today$3.78
High today$3.78
Low today$3.59
Low today$3.59
Open price$3.74
Open price$3.74
Volume25.48K
Volume25.48K
52 Week high$6.12
52 Week high$6.12
52 Week low$2.55
52 Week low$2.55
Stock Snapshot
With a market cap of 40.45M, Lantern Pharma(LTRN) trades at $3.60. The stock has a price-to-earnings ratio of -2.05.
On 2025-12-13, Lantern Pharma(LTRN) stock traded between a low of $3.59 and a high of $3.78. Shares are currently priced at $3.60, which is +0.3% above the low and -4.8% below the high.
The Lantern Pharma(LTRN)'s current trading volume is 25.48K, compared to an average daily volume of 68.55K.
During the past year, Lantern Pharma(LTRN) stock moved between $2.55 at its lowest and $6.12 at its peak.
During the past year, Lantern Pharma(LTRN) stock moved between $2.55 at its lowest and $6.12 at its peak.
People also own
Based on the portfolios of people who own LTRN. This list is generated using Robinhood data, and it’s not a recommendation.